Aardvark Therapeutics Inc (AARD)
SG&A Expense Growth
-21.50%
Quarterly · Period ending:
AARD SG&A Expense Growth
Latest reported-21.50%period ending
Latest reported-21.50%period ending
AARD Quarterly SG&A Growth (QoQ) (0.00% → -21.50%)
Latest values, visible window
High-resolution chart · PNG
AARD sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -21.5025% | |
| 33.8706% | |
| 11.0691% | |
| 46.7259% | |
| -0.442% | |
| 95.6052% | |
| 35.2827% | |
| -49.4581% | |
| 135.7724% | |
| 64% | |
| -2.4164% | |
| 0% |